Access Statistics for Jo Seldeslachts

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on Gas Hub Prices 0 0 0 46 5 8 13 93
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 21 1 2 8 44
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 23 4 5 14 54
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 22 0 3 15 54
A retrospective evaluation of the GDF/Suez merger: Effects on gas hub prices 0 0 0 55 5 5 13 76
Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development 0 0 3 13 5 11 30 44
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 1 16 5 7 19 32
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 2 2 0 1 11 14
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development 1 1 28 28 3 7 58 58
Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development 0 1 13 13 0 2 25 25
Collusion through Joint R&D: An Empirical Assessment 0 0 1 64 2 5 13 127
Collusion through Joint R&D: An Empirical Assessment 0 0 0 78 4 5 12 198
Collusion through joint R&D: An empirical assessment 0 0 0 167 4 7 13 230
Common Ownership Patterns in the European Banking Sector – The Impact of the Financial Crisis 0 0 0 8 1 3 8 18
Common Ownership and Market Entry: Evidence from Pharmaceutical Industry 0 0 0 61 3 6 18 272
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 60 3 10 26 251
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 0 3 4 4 4
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 1 22 2 2 12 75
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 0 15 3 3 6 45
Common Ownership: Europe vs. the US 0 0 1 6 2 7 16 24
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 98 4 8 19 129
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 17 1 2 14 100
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 15 1 2 9 29
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 13 2 4 16 46
Common ownership: Europe vs. the US 0 0 0 5 1 2 12 28
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 44 3 5 13 80
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 34 1 2 6 68
Effective European antitrust: Does EC merger policy generate deterrence? 0 0 0 1 1 1 5 42
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 57 3 6 11 174
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 45 3 3 17 232
Interactions Between Product and Labour Market Reforms 0 0 0 283 5 8 21 1,099
Merger Clusters during Economic Booms 0 0 0 100 0 0 4 395
Merger Failures 0 0 0 450 2 2 14 1,340
Merger failures 0 0 0 229 2 8 24 596
Mergers, Investment Decisions and Internal Organisation 0 0 0 192 1 4 10 480
Mergers, Investment Decisions and Internal Organisation 0 0 0 86 1 1 8 451
Mergers, Investment Decisions and Internal Organisation 0 0 1 6 3 3 11 82
Mergers, Investment Decisions and Internal Organisation 0 0 0 343 6 7 12 1,298
On The Stability of Research Joint Ventures: Implications for Collusion 0 0 0 68 0 0 4 227
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 71 3 4 11 274
Ownership Diversification and Product Market Pricing Incentives 0 0 0 1 0 6 27 32
Ownership Diversification and Product Market Pricing Incentives 0 0 0 17 3 10 34 74
Ownership diversification and product market pricing Incentives 0 0 0 2 2 2 20 28
R&D Spillovers through RJV Cooperation 0 0 0 5 4 5 14 28
R&D Spillovers through RJV Cooperation 0 0 0 9 2 4 10 30
R&D Spillovers through RJV Cooperation 0 0 0 3 4 5 12 38
R&D Spillovers throught RJV Cooperation 0 0 0 18 3 7 29 76
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 48 0 4 18 211
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 51 1 1 7 206
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 69 2 4 11 287
Screening and Merger Activity 0 0 0 91 0 3 13 369
The Contingent Effect of Alliance Design on Alliance Dynamics and Performance: An Experimental Study 0 0 0 30 3 3 11 62
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 32 2 4 8 148
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 15 3 5 17 108
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 108 3 8 13 387
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 96 2 4 9 321
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 2 137 8 13 29 158
US and EU Secure Vaccine Production on Home Soil 0 0 0 13 1 1 3 53
USA und EU setzen auf lokale Impfstoffproduktion - Versorgungssicherheit im Fokus 0 0 0 3 0 0 3 27
What Clients Want: Choices between Lawyers' Offerings 0 0 0 13 3 4 10 62
What Clients want: Choices between Lawyers' Offerings 0 0 0 17 2 4 7 55
What clients want: Choices between lawyers' offerings 0 0 0 2 1 2 13 41
Total Working Papers 1 2 53 3,657 147 274 893 11,709
2 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on the Belgian Gas Hub 0 0 0 0 1 2 7 10
A Retrospective Study of State aid Control in the German Broadband Market 0 1 1 1 2 5 5 5
Ausbau der deutschen Grundbreitbandversorgung: Lehren aus der Vergangenheit mahnen zur Besonnenheit 0 0 0 4 3 3 7 28
Changes in Common Ownership of German Companies 0 0 2 53 2 3 18 192
Collusion Through Joint R&D: An Empirical Assessment 0 0 0 54 4 8 18 214
Common Ownership Patterns in the European Banking Sector—The Impact of the Financial Crisis1 0 0 2 3 0 0 7 10
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 1 3 3 4 7 24 24
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis 0 0 0 0 5 9 12 15
Deutschland muss seine Digitalstrategie überdenken, um den Anschluss nicht zu verlieren: Editorial 0 0 0 3 2 3 8 40
Diversification, Common Ownership, and Strategic Incentives 0 0 0 18 3 5 8 60
EFFECTIVE EUROPEAN ANTITRUST: DOES EC MERGER POLICY GENERATE DETERRENCE? 0 0 0 3 0 3 10 61
EU Competition Policy Enforcement Supports Investment in the Energy Sectors 0 0 0 4 1 2 11 42
EU-Regionalbeihilfen haben positiven Einfluss auf Investitionen 0 0 0 2 0 2 5 17
EU-Wettbewerbspolitik fördert Investitionen in den Energiesektoren 0 0 0 2 0 1 4 34
Effective European Antitrust: Does EC Merger Policy Generate Deterrence? 0 0 0 4 1 1 6 31
Endogenous mergers and endogenous efficiency gains: The efficiency defence revisited 0 0 0 87 3 5 17 288
Europeanization of EU member-state competition policy: The commission's leadership role 0 0 1 14 5 6 9 83
Harte Restriktionen scheinen die wirksamste Maßnahme zu sein, um in einer Pandemie den Flugverkehr zu beschränken: Interview 0 0 0 0 2 2 3 3
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 33 4 5 14 136
Learning dynamics in research alliances: A panel data analysis 0 0 0 32 0 5 12 237
Let’s Not Stick Together: Anticipation of Cartel and Merger Control in The Netherlands 0 0 0 20 6 6 10 97
Mandanten von Anwälten wollen kein Stundenhonorar 0 0 0 1 0 0 2 37
Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert 0 0 0 2 2 2 5 13
Merger Failures 0 1 3 12 3 6 26 195
Nur harte Corona-Regeln wirken sich auf den Passagierflugverkehr zwischen Deutschland und Mallorca aus 0 0 0 1 1 1 4 8
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 0 1 1 7 49
Only Strict Coronavirus Regulations for Vacationers Affect Passenger Air Traffic between Germany and Mallorca 0 0 0 0 0 0 3 14
Paying by the Hour: The Least Appealing Option for Clients of Lawyers 0 0 0 0 0 0 3 46
R&D Spillovers through RJV Cooperation 0 0 0 0 0 3 21 23
R&D spillovers through RJV cooperation 0 0 0 4 1 4 19 43
SCREENING AND MERGER ACTIVITY 0 0 0 0 2 4 13 102
SYNCHRONISING DEREGULATION IN PRODUCT AND LABOUR MARKETS 0 0 0 7 0 2 9 53
Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven 0 0 0 0 0 1 4 32
Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 1 2 50 1 3 17 201
The Deterrence Effects of US Merger Policy Instruments 0 0 1 19 4 7 20 139
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 0 2 6 18 18
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 1 2 8 8 18 20
The Pricing Structure of Legal Services: Do Lawyers Offer What Clients Want? 0 0 1 2 1 5 12 26
The political economy of mobile telecommunications liberalization: Evidence from the OECD countries 0 0 0 70 5 9 20 263
Transformational Strategies and Productivity Growth: A Transformational‐Activities Perspective on Stagnation in the New‐Normal Business Landscape 0 0 0 2 3 3 9 21
US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview 0 0 0 0 1 1 7 10
Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen 0 0 0 3 1 1 3 20
Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview 0 0 0 0 1 1 3 4
Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten 0 0 0 1 1 2 4 10
Total Journal Articles 0 4 17 516 86 153 462 2,974
3 registered items for which data could not be found


Statistics updated 2026-05-06